search
Back to results

Vitamin D Treatment of Diabetic Patients With Foot Ulcers

Primary Purpose

Diabetic Foot Ulcers, Vitamin D Deficiency

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Vitamin D
Placebo
Sponsored by
Zealand University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Diabetic Foot Ulcers

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Age > 18 years
  2. Diagnosed diabetes.
  3. Foot ulcers more than 6 weeks.
  4. Informed consent

Exclusion Criteria:

  1. Pregnancy
  2. Granulomatous diseases such as tuberculosis, sarcoidosis and silicosis
  3. Hypercalcemia
  4. Supplementation of vitamin D > 20 μg a day
  5. Renal disease
  6. Liver disease
  7. Osteomyelitis
  8. Skin cancer.
  9. Epilepsy.
  10. High blod pressure (> 150/100 mmHg).
  11. Indication for surgical revision.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Placebo Comparator

    Arm Label

    Vitamin D

    Placebo

    Arm Description

    supplementation with tablet 170 μg Vitamin D each day.

    Placebo, tablet with 20 μg Vitamin D each day.

    Outcomes

    Primary Outcome Measures

    Wound healing
    Wound healing, measured in square cm

    Secondary Outcome Measures

    Vitamin D blod level status
    Vitamin D blod level status in intervention Group after supplementation.

    Full Information

    First Posted
    January 9, 2019
    Last Updated
    January 21, 2019
    Sponsor
    Zealand University Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03813927
    Brief Title
    Vitamin D Treatment of Diabetic Patients With Foot Ulcers
    Official Title
    Systemic Vitamin D Treatment of Diabetic Patients With Foot Ulcers: a Clinical Controlled Investigation of the Effect on Healing
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    January 2019
    Overall Recruitment Status
    Completed
    Study Start Date
    April 1, 2016 (Actual)
    Primary Completion Date
    December 31, 2017 (Actual)
    Study Completion Date
    July 3, 2018 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Zealand University Hospital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The purpose of this study, is to determine whether daily supplements of vitamin D improves wound healing in diabetic patients with chronic foot ulcers.
    Detailed Description
    Project title "Treatment with oral vitamin D in diabetic patients with chronic foot ulcers on the lower limb; a clinical controlled study of the effect on wound healing". Abstract Aims and objectives The purpose of this study is to determine whether daily supplements of vitamin D improves wound healing in diabetic patients with chronic foot ulcers. Background Lifetime risk of developing chronic lower extremity ulcers summarized in type I and type II diabetics is about 25% and the prevalence is approximately 7%. There is often a long term resource consuming disorder where 47% of the diabetic leg and foot ulcers effectively can be treated within 12 months. In Denmark in 2011 there were more than 300,000 diagnosed type I and type II diabetics, and estimated about 200,000 undiagnosed type II diabetics. Therefore, approximately 35,000 diabetics each year are treated for chronic leg or foot ulcers in the Danish health sector. The treatment of these chronic wounds are associated with significant costs, as well as emotional, physical and financial. Vitamin D deficiency is a widespread problem, and it is estimated that worldwide there is 1 billion people suffering from vitamin D deficiency. A Danish study from 2012 showed vitamin D deficiency in 52% of adults aged 30 60 years. Vitamin D deficiency is more common in diabetics with chronic foot or leg ulcers, when compared with non diabetics and diabetics without ulcers. Methods and materials 48 diabetic patients with chronic foot ulcers will be included in the study. The patients will be recruited from the outpatient clinic, department of orthopaedic surgery at Zealand University Hospital, Denmark. The patients will randomly be divided into two groups, respectively treated with vitamin D or placebo. Expected outcome and perspectives The investigators expect that this study will show that supplementation with oral vitamin D, will result in a significant effect on wound treatment and healing for a large group of diabetic patients with chronic foot ulcers. This will contribute to a changed procedure in this specific group of patients, leading to measurement of vitamin D status and supplementation with vitamin D if needed.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Diabetic Foot Ulcers, Vitamin D Deficiency

    7. Study Design

    Primary Purpose
    Basic Science
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantCare ProviderInvestigator
    Allocation
    Randomized
    Enrollment
    48 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Vitamin D
    Arm Type
    Experimental
    Arm Description
    supplementation with tablet 170 μg Vitamin D each day.
    Arm Title
    Placebo
    Arm Type
    Placebo Comparator
    Arm Description
    Placebo, tablet with 20 μg Vitamin D each day.
    Intervention Type
    Dietary Supplement
    Intervention Name(s)
    Vitamin D
    Intervention Description
    Supplementation with tablet 170 μg Vitamin each day.
    Intervention Type
    Dietary Supplement
    Intervention Name(s)
    Placebo
    Intervention Description
    Placebo with tablet 20 μg Vitamin each day.
    Primary Outcome Measure Information:
    Title
    Wound healing
    Description
    Wound healing, measured in square cm
    Time Frame
    48 weeks or wound healing.
    Secondary Outcome Measure Information:
    Title
    Vitamin D blod level status
    Description
    Vitamin D blod level status in intervention Group after supplementation.
    Time Frame
    48 weeks or wound healing.

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Age > 18 years Diagnosed diabetes. Foot ulcers more than 6 weeks. Informed consent Exclusion Criteria: Pregnancy Granulomatous diseases such as tuberculosis, sarcoidosis and silicosis Hypercalcemia Supplementation of vitamin D > 20 μg a day Renal disease Liver disease Osteomyelitis Skin cancer. Epilepsy. High blod pressure (> 150/100 mmHg). Indication for surgical revision.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Peter Max Halschou-Jensen, MD
    Organizational Affiliation
    Zeeland University Hospital, Denmark
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Vitamin D Treatment of Diabetic Patients With Foot Ulcers

    We'll reach out to this number within 24 hrs